Walgreens — Uncollected Prescription Billing
Walgreens Pays $106.8 Million for Billing Prescriptions Never Dispensed
Source: U.S. Department of Justice
TL;DR: Walgreens Pays $106.8 Million for Billing Prescriptions Never Dispensed This case resulted in a $106.8 Million resolution and demonstrates the impact of whistleblower protections in recovering funds from fraud.
Summary
Walgreens Boots Alliance Inc. and Walgreen Co. agreed to pay $106.8 million to resolve allegations that they billed Medicare, Medicaid, and other government health care programs for prescriptions that were processed but never picked up and therefore never dispensed. DOJ alleged the conduct spanned 2009 through 2020 and reported Walgreens received credit for prior refunds and for disclosure, cooperation, and remediation. DOJ stated the federal settlement resolved multiple whistleblower suits filed by former Walgreens personnel.
Our Take
"Never dispensed" pharmacy billing cases usually trace back to systems and reversals: when claims transmit, what status codes mean, and how (or whether) reversals happen automatically when the drug isn't picked up. Insiders often can pinpoint exactly where controls failed—system configurations, store-level workarounds, training gaps, and exception queues that were ignored. If this feels familiar, the strongest narrative is typically transactional: claim submitted, pickup never occurred, reversal not processed, payment retained—repeated at scale.
Read the full article from the original source:
View Original ArticleOpens in a new tab. Content from U.S. Department of Justice.
Notice
The summaries above are based on publicly available information released by the U.S. Department of Justice and are provided for informational purposes only. They do not constitute legal advice, investigative findings, or allegations by Disclosure Strategy. Our commentary reflects general, experience-based observations about how False Claims Act matters commonly arise and is not a statement about any party's liability.